Analysts divided over BHEL's OFS for retail investors

Analysts are divided on BHEL's ₹4,422 crore offer for sale, with caution on valuation but optimism over its order book. While short-term investors may see no immediate upside, those with a medium to long-term horizon could find merit in bidding. The OFS is seen as a divestment exercise rather than a rerating trigger.